Retour aux projets

18024.1 PFLS-LS

Microfluidic two-tissue platform for combined drug efficacy and toxicity testing

Résumé

Microfluidic two-tissue platform for combined drug efficacy and toxicity testing

Textes supplémentaires

Abstract

Development and commercialization of an end-user validated microphysiological testing platform for combined drug efficacy and toxicity testing. The platform will rely on microfluidics technology and will enable to metabolically interconnect active human 3D liver microtissues with microtissue tumor models. Handling, operation and read-out will be made compatible with cell culturing standards.

Participants

Jens M. Kelm

Wirtschaftspartner

jens.kelm@insphero.com

InSphero AG CHE-114.790.768 Jens M. Kelm Wagistrasse 27 8952 Schlieren ZH CH

Andreas Hierlemann

Kontaktperson

andreas.hierlemann@bsse.ethz.ch

ETH Zürich department of biosystems science an D-BSSE Andreas Hierlemann Mattenstrasse 26 4058 Basel BS CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2016-02-29
Date de fin
2020-02-29
Coûts totaux approuvés
CHF 705676.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Industrielle Produktivität und Technologie

Disciplines de recherche

  • T490 Biotechnology 100.0%